Hypertrophic cardiomyopathy (HCM) is caused by mutations in thin filament regulatory proteins that confer distinct primary alterations of cardiac contractility. We believe that altered Ca 2þ -buffering by mutant thin filaments leads to altered Ca 2þ handling and, via Ca 2þ -dependent signalling pathways, contributes to disease pathogenesis. We are studying the in situ effect on Ca 2þ -flux of a HCM causing mutations in human cardiac troponin T (R92Q), troponin I (R145G) and a-tropomyosin (D175N) by adenoviral expression in adult guinea pig cardiomyocytes. Western blot and immunolocalisation analysis showed that recombinant protein was found at the I band and comprised 50% of the total protein 48 hours after infection. Simultaneous measurement of unloaded sarcomere-shortening and Ca 2þ -transients, showed the HCM mutations had a significant decrease in the basal sarcomere length coupled with an increase in the diastolic Ca 2þ concentration. Caffeine challenging indicated that the SR load was reduced and the sodium calcium exchanger (NCX) dependant tau decay time was increased in the HCM mutant cells. Ca 2þ -dependent signalling cascades were assessed by observing, the nuclear translocation of the transcription factor NFAT by immunofluorescence. Chronically paced HCM mutant cells had a~2.5 fold increase in nuclear NFAT compared to unpaced or wild type infected cells. A potential mechanism for this was ryanodine receptor leak which was increased~7 fold in cTnI R145G mutant cells. The same mutation reduced the ability of the SR to respond to PKA dependant contractile sensitization, upon Isoproterinol treatment. These data strongly implicate Ca 2þ -buffering as a driving mechanism of the macroscopic remodelling observed in the pathological disease state of HCM. Ca 2þ Buffering is now being directly measured by simultaneously integrating the NCX current of patch clamped mutant cardiomyocytes, as the cells are challenged with caffeine. Saitama Medical University, Saitama, Japan. There is substantial evidence indicating that disruption of Ca 2þ homeostasis and activation of cytosolic proteases play a key role in the pathogenesis of Duchenne Muscular Dystrophy (DMD). However, the exact nature of the Ca 2þ deregulation and Ca 2þ signaling pathways that are altered in dystrophic muscles have not yet been resolved. Here we examined the contribution of the store-operated Ca 2þ entry (SOCE) for the pathogenesis of DMD. RT-PCR and Western blot found that the expression level of Orai1, the pore-forming unit of SOCE, was significantly elevated in the dystrophic muscles, while parallel increases in SOCE activity and SR Ca 2þ storage were detected in adult mdx muscles using Fura-2 fluorescence measurements. High-efficient shRNA probes against Orai1 were delivered into the flexor digitorum brevis muscle in live mice and knockdown of Orai1 eliminated the differences in SOCE activity and SR Ca 2þ storage between the mdx and wild type muscle fibers. SOCE activity was repressed by intraperitoneal injection of BTP-2, an Orai1 inhibitor, and cytosolic calpain1 activity in single muscle fibers was measured by a membrane-permeable calpain substrate. We found that BTP-2 injection for 2 weeks significantly reduced the cytosolic calpain1 activity in mdx muscle fibers. Additionally, ultrastructural changes were observed by EM as an increase in the number of triad junctions was identified in dystrophic muscles. Compensatory changes in protein levels of SERCA1, TRP and NCX3 appeared in the mdx muscles, suggesting that comprehensive adaptations occur following altered Ca 2þ homeostasis in mdx muscles. Our data indicates that upregulation of the Orai1-mediated SOCE pathway and an overloaded SR Ca 2þ store contributes to the disrupted Ca 2þ homeostasis in mdx muscles and is linked to elevated proteolytic activity, suggesting that targeting Orai1 activity may be a promising therapeutic approach for the prevention and treatment of muscular dystrophy. ] i sufficiently to increase SR Ca 2þ -loading via t-tubular Na/Ca exchange, thus increasing CaTamplitude, which helps to protect contraction. We find that NHE activity (rat ventricular myocytes) also affects Ca 2þ -signalling spatially. A longitudinal pH i non-uniformity can be induced by microperfusion of the weak acid, acetate (80mM), over one end of the cell. pH i falls in the acetate-exposed region, resulting in a stable pH i -gradient of~0.6 units. With NHE inhibited (30mM cariporide), this procedure persistently reduced CaT amplitude, but only in the acidic region. With functional NHE (no cariporide), the same stably-imposed pH i-gradient increased CaT-amplitude uniformly throughout the myocyte. This occurred despite NHE being stimulated only at the acidic end of the cell. One explanation is that local Na þ -influx during regional NHE-stimulation uniformly elevates [Na þ ] i , thus increasing SR Ca 2þ -loading in both acidic and non-acidic regions. This requires that cytoplasmic Na þ be readily diffusible, as NHE protein is mainly expressed at surface sarcolemma and intercalateddisks (not in transverse-tubules). We therefore imaged [Na þ ] i (AM-loaded SBFI) during localised NHE-stimulation (local acetate microperfusion, rest of cell exposed to Na-free solution; 10 À6 M strophanthidin throughout to inhibit Na/K-transporters). This induced a local NHE-mediated [Na þ ] i -rise, which dissipated longitudinally, with an apparent diffusion-coefficient of 680mm 2 /s (~50% of that in pure water), consistent with rapid Na þ i -mobility. We therefore propose that high Na We are developing a novel technology for selective delivery of imaging probes and membrane-impermeable molecules to cells with low extracellular pH. It is based on action of water-soluble membrane peptide, pHLIP Ò (pH [Low] Insertion Peptide), which inserts and folds in cellular membrane at slightly acidic environment, characteristic for various pathological states including cancer and ischemic myocardium. pHLIP possess dual delivery capability. Imaging agents (fluorescent, PET, SPECT or MRI) could be attached to the N-terminus of the peptide to mark tumor mass and tumor margins with high precision. At the same time, therapeutic molecules attached to the C-inserting end, could be moved across membrane to reach cytoplasmic target. Among translocated molecules are synthetic cyclic peptides, gene regulation agent (peptide nucleic acid) and phalla-and amanita toxins with hydrophobicity tuned by attachment of fatty acids for optimum delivery. We performed sequence variation and investigated 16 pHLIP variants with main goals of understanding the main principles of peptide-lipid interactions and tune delivery capability of pHLIP. The biophysical studies including thermodynamics and kinetics of the peptides interaction with a lipid bilayer of liposomes and cellular membranes were carried out. We found that peptides association to membrane at neutral and low pH could be modulated by 3-4 times. The apparent pK of transition from surface bound to membrane-inserted state could be tuned from 6.5 to 4.5. The rate of peptide's insertion across a bilayer could be enhanced 100 times compared to parent pHLIP. As a result, blood clearance and tumor targeting were modulated in a significant degree.
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